Caution! The site can't guarantee, that text has age permission. The site is not recommended, if you are less than 18 years old.
The site shows example sentences for English words. How the word or phrase could be used in a sentence?
" ... Our final Top Short today is Tetraphase Pharmaceuticals, a biopharmaceutical company that uses their proprietary technology to create, develop, and commercialize novel tetracyclines for serious and life-threatening conditions. The stock has shed 7.85% year-to-date, but longer term losses are an issue for the stock with factor scores identified from our AI systems of C in Technical, F in Momentum Volatility, and C in Quality Value. Revenue grew by 6.53% in the last fiscal year to $7.38M from $9.67M three years ago. Operating Income grew by 10.08% but was negative $(67.2)M in the last fiscal year, a growth of 47.78% over the last three fiscal years from $(115.72)M. EPS was negative $(22.85) but at least it grew by 41.75% in the last fiscal year, from a negative $(52.66) three years ago – a growth of 74.72% over the last three fiscal years. ROE was (136.3%) in the last year compared to (84.9%) three years ago. Forward 12M revenue is expected to grow by 24.95%. ... "
" ... Our final Top Short today is Tetraphase Pharmaceuticals, which was rated C in Technical, F in Momentum Volatility, and C in Quality Value by our AI technology. The stock appears to be in a slow, prolonged death for years, and is down an additional 20.48% for the year. The company operates in the biopharmaceutical space, using its proprietary chemistry technology to create, develop, and commercialize novel tetracyclines for serious and life-threatening conditions. Revenue grew by 6.53% in the last fiscal year, with operating income growing by 10.08%. Operating income also grew by 47.78% over the last three. EPS was a bright spot and grew by 41.75% in the last fiscal year, continuing a strong trend and growing by 74.72% over the last three. Revenue was $7.38M in the last fiscal year compared to $9.67M three years ago, a slowing trend which could become a problem down the road. While the percentage gains were ok, when you drill into the financial numbers, it is less positive. Operating income was $(67.2) million in the last fiscal year, better than $(115.72) million three years ago, but still well into the negative. EPS was no better at $(22.85) in the last fiscal year, better than the dismal $(52.66) three years ago, however. ROE is trending worse for the company with (136.3%) in the last year, compared to (84.9%) three years ago. Revenue is expected to grow by 24.95% over the next 12 months. ... "